Iron Oxide Nanoparticles with Cucurbituril[7] for Targeted Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery systems for cytotoxic drugs are non-selective, leading to significant side effects due to systemic administration, and lack the ability to target cancer cells effectively, while diagnostic and imaging challenges persist in tumor evolution.
Innovation Solution
Surface functionalized iron oxide nanoparticles with cucurbituril[7] (CB[7]) are used for drug delivery and imaging, allowing for targeted cargo release through an alternating magnetic field, enhancing drug concentration in tumors and providing imaging capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cytotoxic drugs are administered systemically to shrink tumors, then therapeutic effect is achieved, but side effects increase due to non-selective killing of healthy cells
Solution Approach 1:
The patent segments the drug delivery system into multiple functional components: iron oxide nanoparticles for magnetic targeting, CB[7] macrocycles for drug encapsulation, and surface functional groups for stability. This segmentation allows each component to perform its specific function, enabling selective delivery to tumors while protecting healthy tissues from systemic exposure to cytotoxic drugs
Solution Approach 2:
The patent uses an alternating magnetic field as an intermediary to trigger controlled drug release at the tumor site. The magnetic field acts as a remote control mechanism that activates cargo release only in the targeted tumor region, preventing premature release during circulation and minimizing exposure to healthy cells
2Quantity of substance
If large doses of non-selective drugs are injected to ensure sufficient amounts reach tumors, then therapeutic coverage is improved, but toxicity to healthy cells increases
Solution Approach 1:
The patent extracts the drug from the systemic circulation environment and concentrates it specifically at the tumor site through magnetic targeting. By taking the drug out of the general circulation and delivering it selectively to the tumor, the system achieves high local concentration with low systemic dosage, thereby reducing toxicity to healthy cells
Solution Approach 2:
The patent creates local quality by concentrating the therapeutic agent specifically at the tumor location through magnetic guidance. The drug delivery system exhibits different behavior in different locations: remaining stable during circulation (low release) and releasing cargo only at the magnetically targeted tumor site (high release), thus achieving high local concentration without proportionally increasing systemic toxicity
3Quantity of substance
If conventional delivery systems are used to improve drug solubility, then solubility is enhanced, but targeting capability is lost
Solution Approach 1:
The patent merges multiple functions into a single nanocarrier system: the iron oxide core provides magnetic targeting capability, the CB[7] macrocycle layer provides drug encapsulation and solubility enhancement, and the surface functional groups provide colloidal stability. This merging allows the system to simultaneously achieve solubility improvement and active magnetic targeting, overcoming the limitation of conventional delivery systems that only address solubility
4Adaptability or versatility
If nanoparticles are used for both drug delivery and imaging, then diagnostic capability is added, but system complexity increases
Solution Approach 1:
The patent implements universality by designing the iron oxide nanoparticle-CB[7] complex to perform multiple functions: magnetic resonance imaging contrast enhancement, magnetic targeting guidance, and controlled drug release. The same nanoparticle structure serves as both diagnostic agent and therapeutic delivery vehicle, eliminating the need for separate diagnostic and therapeutic systems and thereby managing complexity through functional integration rather than adding separate components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables selective drug delivery to cancer cells, reducing side effects and improving diagnostic imaging, with controlled release of cargo at tumor sites, combining chemotherapy and thermal ablation for effective cancer treatment.
Implementation Method 1
The nanoparticles may be guided to desired locations by the use of magnets
Implementation Method 2
an alternating magnetic field may be used to effect an increase in temperature thereby causing release of cargo from the nanoparticles
Implementation Method 3
Various agents can be loaded into the hydrophilic cavity of the CB[7] macrocycles
Data Source
AI summary
Provided are compositions and methods for transport, monitoring the transport, and controlled release of active agents. The compositions comprise surface functionalized iron oxide nanoparticles. The iron oxide nanoparticles are surface functionalized with cucurbitril[7] macrocycles. The cavity formed by the CB[7] macrocycles can be used for storage and transport of active agents. The active agents may be imaging agents or may be therapeutic agents which can be released by applying an alternating magnetic field at desired locations.